Does ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT Cause Wrong technique in product usage process? 20 Reports in FDA Database

Q: Does ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT cause Wrong technique in product usage process?

20 reports of Wrong technique in product usage process have been filed with the FDA for ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT, representing 0.2% of all ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT adverse event reports.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Wrong technique in product usage process have been filed in association with ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT. This represents 0.2% of all adverse event reports for ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT.

Reports of Wrong technique in product usage process with ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT

0.2%

of all ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT reports

Deaths

Hospitalizations

How Dangerous Is Wrong technique in product usage process From ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT?

Of the 20 reports, 6 (30.0%) required hospitalization, and 1 (5.0%) were considered life-threatening.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT Cause?

Haemarthrosis (3,360) Haemorrhage (2,925) Fall (709) Arthralgia (561) Muscle haemorrhage (554) Limb injury (525) Drug ineffective (513) Joint injury (511) Contusion (496) Pain (484)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT Alternatives Have Lower Wrong technique in product usage process Risk?

ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs ANTIHEMOPHILIC FACTOR PORCINE, B-DOMAIN TRUNCATED RECOMBINANT ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs APALUTAMIDE ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs APATINIB

ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT Demographics